DoJ, Congress Want Ad Oversight: FDA Sounds Ready To Respond
Executive Summary
The Department of Justice's level of interest in drug industry promotional issues seems to be increasing, FDA Division of Drug Marketing, Advertising & Communications Director Tom Abrams told the Food & Drug Law Institute advertising and promotion conference Sept. 8
You may also be interested in...
Advertising Citations Reach Record High: Another Way To Regulate Pharma?
FDA's Division of Drug Marketing, Advertising and Communications has sent half of this year's citations for misleading advertising in the past month
Advertising Citations Reach Record High: Another Way To Regulate Pharma?
FDA's Division of Drug Marketing, Advertising and Communications has sent half of this year's citations for misleading advertising in the past month
FDA’s Advertising Enforcement Turns Its Focus To YouTube, ADHD Drugs
FDA's spate of five promotional citations to manufacturers of attention deficit/hyperactivity disorder drugs signals that the agency intends to remain vigilant in oversight of new media